These final results, together with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 guidance the thought of focusing on ACKR3 as a unique method to modulate the opioid process, which could open new therapeutic avenues for opioid-associated Diseases. Gene expression Investigation uncovered https://johna703dyt1.activablog.com/profile